drugset / Trial / NCT05828238

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

NCT05828238 ↗

Phase 0 Unknown 10 enrolled Affiliated Hospital of Jiangnan University
NaSingle-groupOpen-labelDiagnostic

Summary

This is a single arm study to determining the value of apoptotic molecular probe SF-DEVD-2 in the early evaluation of tumor efficacy and comparing it head-to-head wihe 18F-FDG(18F-2-fluoro-2-deoxy-D-glucose)

Timeline

Start
2023-01
Primary completion
2024-01
Completion
2024-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-2-fluoro-2-deoxy-D-glucose Unknown — —
Subject SF-DEVD-2 Diagnostic / imaging agent — —

Indications